Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient

This study has been completed.
Information provided by (Responsible Party):
Mundipharma (China) Pharmaceutical Co. Ltd Identifier:
First received: November 17, 2011
Last updated: August 10, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)